CA2017767A1 - M143-37f11 antibiotique anticancereux, production et utilisation - Google Patents

M143-37f11 antibiotique anticancereux, production et utilisation

Info

Publication number
CA2017767A1
CA2017767A1 CA2017767A CA2017767A CA2017767A1 CA 2017767 A1 CA2017767 A1 CA 2017767A1 CA 2017767 A CA2017767 A CA 2017767A CA 2017767 A CA2017767 A CA 2017767A CA 2017767 A1 CA2017767 A1 CA 2017767A1
Authority
CA
Canada
Prior art keywords
substance
production
activity
anticancer antibiotic
mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2017767A
Other languages
English (en)
Other versions
CA2017767C (fr
Inventor
Masaaki Ishizuka
Hiroyuki Kumagai
Tsutomu Sawa
Hiroshi Naganawa
Hironobu Iinuma
Kunio Isshiki
Masa Hamada
Kenji Maeda
Tomio Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of CA2017767A1 publication Critical patent/CA2017767A1/fr
Application granted granted Critical
Publication of CA2017767C publication Critical patent/CA2017767C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002017767A 1989-05-31 1990-05-29 M143-37f11 antibiotique anticancereux, production et utilisation Expired - Fee Related CA2017767C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1136181A JP2802097B2 (ja) 1989-05-31 1989-05-31 新規な制癌抗生物質ｍｉ４３―３７ｆ１１及びその製造法
JP136,181/89 1989-05-31

Publications (2)

Publication Number Publication Date
CA2017767A1 true CA2017767A1 (fr) 1990-11-30
CA2017767C CA2017767C (fr) 1999-12-14

Family

ID=15169235

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002017767A Expired - Fee Related CA2017767C (fr) 1989-05-31 1990-05-29 M143-37f11 antibiotique anticancereux, production et utilisation

Country Status (11)

Country Link
US (1) US5096924A (fr)
EP (1) EP0401138B1 (fr)
JP (1) JP2802097B2 (fr)
KR (1) KR0135600B1 (fr)
CN (1) CN1028542C (fr)
AT (1) ATE124691T1 (fr)
CA (1) CA2017767C (fr)
DE (1) DE69020645T2 (fr)
DK (1) DK0401138T3 (fr)
ES (1) ES2074148T3 (fr)
GR (1) GR3017577T3 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08176138A (ja) * 1994-12-19 1996-07-09 Mercian Corp イソクマリン誘導体
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
JPH09169756A (ja) * 1995-10-16 1997-06-30 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｅｉ−１９４１類
CN1098258C (zh) * 1996-06-17 2003-01-08 美露香株式会社 异香豆素衍生物及其在医药上的应用
JP4585644B2 (ja) * 2000-01-24 2010-11-24 明治製菓株式会社 新規物質ｐｆ１２２３およびその製造法
CN1277441C (zh) * 2001-01-31 2006-09-27 三洋电机株式会社 无线基地系统和信道分配方法
KR100470975B1 (ko) * 2001-12-12 2005-03-08 한국생명공학연구원 Ａｇｉ-7 화합물과 세스칸델린의 효율적 제조방법
CN1506359A (zh) 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
MA41013A (fr) * 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN110672711B (zh) * 2019-10-22 2021-09-21 南通市第二人民医院 一种肿瘤分子的离子计数检测装置

Also Published As

Publication number Publication date
JP2802097B2 (ja) 1998-09-21
CA2017767C (fr) 1999-12-14
DK0401138T3 (da) 1995-11-20
KR0135600B1 (ko) 1998-04-23
ES2074148T3 (es) 1995-09-01
EP0401138A2 (fr) 1990-12-05
CN1028542C (zh) 1995-05-24
ATE124691T1 (de) 1995-07-15
GR3017577T3 (en) 1995-12-31
EP0401138A3 (fr) 1991-04-10
US5096924A (en) 1992-03-17
KR900017582A (ko) 1990-12-19
DE69020645T2 (de) 1995-11-30
DE69020645D1 (de) 1995-08-10
CN1047696A (zh) 1990-12-12
EP0401138B1 (fr) 1995-07-05
JPH032177A (ja) 1991-01-08

Similar Documents

Publication Publication Date Title
CA2009508A1 (fr) Substance pf 1022, methode de fabrication et composition anthelmintique la renfermant
CA2412554A1 (fr) Morphines 3-substituees
EP0401138A3 (fr) Substance antibiotique anticancéreuse, sa production et ses usages
EP0225292A3 (fr) Certains dérivés de butyramide N-substitués
CA2044619A1 (fr) Methode de synthese de cetones insaturees en .alpha.,.beta.
CA2096970A1 (fr) Derive anilide
CA2042053A1 (fr) Analogues monosaccharidiques de lipide a
CA2188181A1 (fr) Preparation de purines
CA2092705A1 (fr) Compose presentant une action antitumorale, nsc-lsc1, et procede de fabrication dudit compose
JPS5758884A (en) Preparation of glutathione peroxidase
CA2003852A1 (fr) Preparation de n-acylaminomethylphosphonates
CA2210041A1 (fr) Cyclodextrines ramifiees et methode de production de ces dernieres
EP0331089A3 (fr) Glycoside contenant du fluor et son utilisation
EP0350623A3 (fr) Antibiotique antitumoral BU3420T
KR900003187A (ko) 백금(ⅳ)-디아민 착물, 이 화합물의 제조방법, 최소한 하나의 백금 화합물을 포함하는 항종양 활성을 갖고 있는 제제, 항종양 활성을 갖고있는 제형화된 제제
IE39141L (en) Production of immunological material
EP0249013A3 (en) Process for producing alkyloligoglycosides
CA2113656A1 (fr) Isolement et structure de la spongistatine 1
CA2158712A1 (fr) Methode de preparation d'alcoxytriazolinones
CA2008628A1 (fr) Substance uct-1003 et procede de production
KR890014457A (ko) 신규 아족시 화합물 및 그의 제조방법
AU6900291A (en) Process for securing components and assembly base for implementing the process
PL338514A1 (en) Macrolydes of anticarcinogenic activity
CA2041237A1 (fr) Composes ucf1 et leurs derives; methode de preparation
EP0387860A3 (fr) Antibiotique antitumoral BMY41339

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed